← Database
Copper Tripeptide

AHK-Cu

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

A copper-binding tripeptide (Ala-His-Lys) studied mainly in cosmetic and preclinical settings, with limited human data.

How it works

AHK-Cu is a short chain of three amino acids (alanine, histidine, and lysine) that carries a copper ion. Copper-binding peptides like this one are studied because copper is an essential trace metal involved in tissue repair, collagen formation, and the activity of several enzymes. By packaging copper into a small, skin-compatible peptide, the idea is to deliver the metal to cells in a controlled way.

Most of the interest in AHK-Cu comes from skin and hair research, where copper peptides have been explored as ingredients that may support the cells and structural proteins of the skin and hair follicle. In laboratory and animal studies, copper tripeptides have been reported to influence cells that build connective tissue and to interact with growth-related signaling. It is often grouped conceptually with the better-known copper peptide GHK-Cu.

The honest takeaway is that high-quality human evidence for AHK-Cu is sparse. Much of what is claimed rests on cell-culture work, animal models, and cosmetic formulation studies rather than rigorous clinical trials. It is not an approved drug, and its biological effects in people remain largely uncharacterized.

Mechanism · Detailed Analysis
Molecular targetAHK-Cu is a copper(II)-chelating tripeptide (Ala-His-Lys); the histidine and terminal amine coordinate the copper ion. Its proposed activity is tied to copper delivery and to interactions with skin and follicle cells rather than a single well-defined receptor.
Signaling & downstream effectsCopper peptides are reported in preclinical work to modulate extracellular matrix turnover and to support dermal fibroblast and follicular cell activity, with copper acting as a cofactor for enzymes such as lysyl oxidase and superoxide dismutase. Downstream effects on collagen, elastin, and angiogenesis are hypothesized but not firmly established in humans.
PharmacokineticsHuman pharmacokinetic data are essentially absent. Small peptides applied topically have limited and variable skin penetration, and copper homeostasis is tightly regulated systemically, so meaningful absorption and distribution after typical cosmetic use are uncertain.
CaveatsEvidence is mostly cosmetic and preclinical; rigorous clinical efficacy and safety data are lacking. It is not an approved therapeutic, and copper-loading or formulation differences make claims hard to generalize.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.